Literature DB >> 14615542

Islet regeneration during the reversal of autoimmune diabetes in NOD mice.

Shohta Kodama1, Willem Kühtreiber, Satoshi Fujimura, Elizabeth A Dale, Denise L Faustman.   

Abstract

Nonobese diabetic (NOD) mice are a model for type 1 diabetes in humans. Treatment of NOD mice with end-stage disease by injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and permanently restores normoglycemia. The return of endogenous insulin secretion is accompanied by the reappearance of pancreatic beta cells. We now show that live donor male or labeled splenocytes administered to diabetic NOD females contain cells that rapidly differentiate into islet and ductal epithelial cells within the pancreas. Treatment with irradiated splenocytes is also followed by islet regeneration, but at a slower rate. The islets generated in both instances are persistent, functional, and apparent in all NOD hosts with permanent disease reversal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615542     DOI: 10.1126/science.1088949

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  98 in total

1.  When the immune system goes on the attack.

Authors:  Vicki Brower
Journal:  EMBO Rep       Date:  2004-08       Impact factor: 8.807

Review 2.  Generation of surrogate beta cells from tissue stem cells.

Authors:  Shimon Efrat
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

3.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

4.  Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.

Authors:  Saeed Khalili; Younan Liu; Yoshinori Sumita; Ola M Maria; David Blank; Sharon Key; Eva Mezey; Simon D Tran
Journal:  Int J Biochem Cell Biol       Date:  2010-08-21       Impact factor: 5.085

Review 5.  Development of the endocrine pancreas.

Authors:  David J Hill
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

6.  In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells.

Authors:  L Baeyens; S De Breuck; J Lardon; J K Mfopou; I Rooman; L Bouwens
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

Review 7.  Cellular therapies for type 1 diabetes.

Authors:  D D Lee; E Grossman; A S Chong
Journal:  Horm Metab Res       Date:  2008-02       Impact factor: 2.936

8.  Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.

Authors:  Francisco Dieguez-Acuña; Shohta Kodama; Yoshiaki Okubo; Ana Cristina Paz; Steven P Gygi; Denise L Faustman
Journal:  Int J Biochem Cell Biol       Date:  2009-12-18       Impact factor: 5.085

9.  Efficient differentiation of insulin-producing cells from skin-derived stem cells.

Authors:  W Guo; C Miao; S Liu; Z Qiu; J Li; E Duan
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

Review 10.  Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia.

Authors:  Hyun Joon Paek; Courtney Kim; Stuart K Williams
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.